Membrane Signaling Networks, Atherosclerosis Research Unit, Department of Medicine, Karolinska Institutet, Karolinska University Hospital-Solna, Stockholm, Sweden.
J Hypertens. 2009 Dec;27(12):2452-7. doi: 10.1097/HJH.0b013e328330cf15.
Because a newly described salt-inducible kinase 1 (SIK1) network is responsible for increases in active cell sodium transport in response to elevated intracellular sodium, we hypothesized that this network could mediate the effects of the mutant (hypertensive) form of alpha-adducin on Na,K-ATPase activity.
Studies were performed in normotensive and hypertensive Milan rats and in a cell line of proximal tubule origin expressing transiently variants of alpha-adducin (human G460W/S586C; rat F316Y) that are associated with elevated blood pressure and result in increased Na,K-ATPase activity. Na,K-ATPase activity was determined as ouabain-sensitive rubidium transport.
SIK1 activity (T182 phosphorylation) was significantly elevated in renal proximal tubule cells from Milan hypertensive rats (carrying a alpha-adducin mutation) when compared with normotensive controls. Similarly, SIK1 activity (T182 phosphorylation) was elevated in a normal renal proximal tubule cell line when transfected with the alpha-adducin variant carrying the human hypertensive mutation. Blocking the SIK1 network using negative mutants as well as different stages of its activation pathway prevented the effects induced by the hypertensive alpha-adducin.
The SIK1 network may constitute an alternative target by which agents can modulate active sodium transport in renal epithelia and avoid the increases in systemic blood pressure that are associated with genetic mutations in the human alpha-adducin molecule.
由于新描述的盐诱导激酶 1(SIK1)网络负责增加细胞内钠水平升高时的活性细胞钠转运,我们假设该网络可以介导突变(高血压)形式的α辅肌动蛋白对 Na,K-ATP 酶活性的影响。
在正常血压和高血压米兰大鼠以及表达瞬时变体α辅肌动蛋白(人 G460W/S586C;大鼠 F316Y)的近端肾小管细胞系中进行了研究,这些变体与血压升高有关,并导致 Na,K-ATP 酶活性增加。Na,K-ATP 酶活性通过哇巴因敏感的铷转运来确定。
与正常血压对照组相比,来自米兰高血压大鼠(携带α辅肌动蛋白突变)的肾近端小管细胞中 SIK1 活性(T182 磷酸化)显着升高。同样,当用携带人类高血压突变的α辅肌动蛋白变体转染正常肾近端小管细胞系时,SIK1 活性(T182 磷酸化)升高。使用负突变体以及其激活途径的不同阶段阻断 SIK1 网络可防止由高血压α辅肌动蛋白引起的作用。
SIK1 网络可能构成替代靶标,通过该靶标可以调节肾上皮细胞中的活性钠转运,并避免与人类α辅肌动蛋白分子中的遗传突变相关的全身血压升高。